Aspect Biosystems and Novo Nordisk have just announced they are deepening their collaboration to accelerate advanced cellular medicines that aim to deliver functional cures for diabetes.

Membrion has been named to Cleantech Group’s 2026 Global Cleantech 100, a list recognizing private companies poised to deliver significant environmental and infrastructure impact in the coming decade.

Pangaea Ventures is proud to double down with Ardent, joining their just-announced Series B. Ardent’s exceptional membrane chemistry is built to solve what others can’t. With real-world deployments scaling and a committed, visionary team at the helm, Ardent stands poised to redefine the future of industrial separations across chemicals, energy, and broader heavy industry.

Ardent has annouced the first close of its Series B co-led by Pangaea Ventures and Xplor Ventures, with participation from Syensqo Ventures and Chevron Technology Ventures.

With Series B funding, pH7 is poised to expand commercial production, refine and enter new verticals, and accelerate industry adoption of their closed-loop metals recovery platform. As partners and champions from the earliest days, Pangaea Ventures is thrilled to double down, investing alongside leaders who redefine what’s possible for clean industry and a healthier planet. Here’s why we’re doing it.

Pangaea Ventures is pleased to announce our participation in pH7 Technologies’ just-announced $25.6 million Series B financing, led by Fine Structure Ventures with participation from BHP Ventures, Energy & Environment Investment (EEI), Siteground, Gaingels, Calm Venture, and other existing investors

Pangaea portfolio company Membrion and Lam Research, a global leader in semiconductor manufacturing solutions, have just announced their partnership to address expensive and critical environmental challenges in semiconductor manufacturing.

Pangaea’s investment in Membrion represents a convergence of advanced materials science, technical rigor, impact-driven innovation, and accelerating customer interest, the hallmarks of the companies we champion to drive planetary health. 

Pangaea Ventures and the Arizona Commerce Authority hosted the Semicon West Startup Social during Semicon West’s first conference in Phoenix, a curated gathering of global semiconductor industry leaders highlighting Phoenix’s emergence as a vital node in the global semiconductor ecosystem.

Pangaea Ventures is pleased to announce our participation in Membrion’s $20 Million Series B1 funding, alongside PureTerra, Lam Research, Ecolab, W.L. Gore & Associates., and other existing investors. 

Tidal Grow® Spectra™, developed by Tidal Grow, a division of Pangaea Ventures portfolio company Tidal Vision, has been approved for California specialty crops

Kanvas Biosciences has taken another leap forward with the announcement of their new Good Manufacturing Practices (GMP) facility in South San Francisco.

Aspect Biosystems has released preclinical data highlighting the potential of their adrenal Bioprinted Tissue Therapeutics to restore adrenal function and treat primary adrenal insufficiency.

Vestaron has been granted emergency use approval in Portugal for its SPEAR® LEP bioinsecticide to protect high-value tomato crops from devastating pests.

Pangaea Ventures portfolio company Ardent has reached a major milestone with the commercial implementation of its Optiperm™ olefin-paraffin separation technology by Braskem, the largest polyolefins producer in the Americas.

Pangaea Ventures is proud  to share that AEPONYX, a Pangaea Ventures portfolio company, has been acquired by Pasqal, a global leader in quantum computing.

We're excited to announce our participation in the oversubscribed $18.7M Series A financing for ChEmpower, a company that's pioneering a revolutionary approach to semiconductor manufacturing.

Kanvas Biosciences, a Pangaea Ventures portfolio company, has published new research on its High-Phylogenetic-Resolution Spatial Mapping (HiPR-Map) Platform spectral imaging technology. This novel tool promises to transform how researchers visualize and analyze the complexities of the microbiome.

Calysta and Marsapet have launched the first complete dog food featuring FeedKind Pet protein, a cultured protein fermented without using any arable land or animal ingredients.